在接受抗凝剂的患者口腔手术后术后出血的分析:一项回顾性研究
Jae-Il Lee1, Hyejun Seo1, Yeong-Cheol Cho2
1Department of Dentistry, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan 44033, Republic of Korea.
Medicina (Kaunas, Lithuania)
|March 27, 2025
概括
在接受口腔手术的抗凝血剂患者中,确定了出血并发症的预测因素. 治疗范围中的时间,INR和NOAC类型是重要的因素,有助于更好的患者管理和结果.
科学领域:
- 在口腔外科手术.
- 药理学 药理学是指药理学的学科.
- 医疗信息学 医疗信息学
背景情况:
- 服用抗凝血剂 (华法林,NOACs) 的患者在口腔手术期间有增加的出血风险.
- 识别出血预测因素对于管理这些患者至关重要.
- 轻微的口腔手术对术后出血并发症有很大的风险.
研究的目的:
- 评估在接受轻微口腔手术的抗凝剂患者中出血并发症的预测因素.
- 分析抗凝剂类型与出血风险之间的关联.
- 改进服用抗凝剂的口腔手术患者的术前和术后评估.
主要方法:
- 对206名患者的医疗和牙科记录 (2015-2023) 的回顾性审查.
- 患者被分为华法林和NOAC组.
- 使用千平方,费舍尔的精确测试和学生的t测试进行统计分析.
主要成果:
- 在206名患者中,有84名患者出现出血并发症.
- 华法林组:治疗范围内的时间 (TTR) 和与出血相关的INR.
- NOAC组:与出血相关的NOAC类型.
- 在这两组中,外科手术期间出血与术后出血相关.
结论:
- 与抗凝剂相关的特定因素预测了口腔手术患者的术后出血.
- 识别这些预测因素可以提高患者管理和手术结果.
- 改善手术前和后的评估可以降低出血风险.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
583
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
583
Esophageal Varices-II: Clinical Features and Management
32
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
32
Disorders of Hemostasis
671
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
671
Tonsillitis II: Management
98
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
98
Extrinsic and Intrinsic Pathways of Hemostasis
4.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.3K
Introduction to Hemostasis
4.6K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
4.6K


